acne_doctor.jpg

If all else fails, it’s time to go to the doctor. A dermatologist will give you a choice of treatments based on what your skin type is and what sort of acne you have. This article discusses some of the treatments. These can be broadly classified into the following :
• Topical (externally applied) antibiotics and antibacterials: These include erythromycin, clindamycin (Benzaclin), sulfacetamide (Klaron), and azelaic acid (Azelex).

• Retinoids: Retin-A (tretinoin) has been around for years, and has become milder and gentler while still maintaining its effectiveness. Newer retinoids include adapalene (Differin) and tazarotene (Tazorac). These medications are especially helpful for unclogging pores. Side effects may include irritation and mild increase in sensitivity to the sun. Wit proper sun protection, however, they can be used even during sunny periods.

• Oral antibiotics: Most doctors start treatment with tetracycline or one of the related “cyclines,” such as doxycycline and minocycline. Other oral antibiotics that are useful for treating acne are cefadroxil, amoxicillin, and the sulfa drugs.

• Problems with these drugs can include allergic reactions (especially sulfa), gastrointestinal upset, and increased sun sensitivity. Doxycycline, in particular, is generally safe but can sometime cause esophagitis (irritation of the oesophagus, producing discomfort when swallowing) and an increased tendency to sunburn.

• Despite many people’s concerns about using oral antibiotics for several months or longer, such use does not “weaken the immune system” and make them more susceptible to infections, or unable to use other antibiotics when necessary.

• Recently published reports that long-term antibiotic use may increase the risk of breast cancer will require further study, but at present are not substantiated. In general, doctors prescribe oral antibiotic therapy for acne only when necessary and for as short a time as possible.

These are a few basic antibiotic treatments more follow in the next article.